- Home
- RPRX vs DOW Comparison
RPRX vs DOW Comparison
Compare RPRX & DOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | DOW |
|---|---|---|
| Founded | 1996 | 1897 |
| Country | United States | United States |
| Employees | N/A | 35700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 27.8B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RPRX | DOW |
|---|---|---|
| Price | $57.48 | $30.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | ★ $51.40 | $39.13 |
| AVG Volume (30 Days) | 2.6M | ★ 10.2M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | 1.90% | ★ 3.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | $2,378,193,000.00 | ★ $39,968,000,000.00 |
| Revenue This Year | $38.63 | $5.40 |
| Revenue Next Year | $4.73 | $2.33 |
| P/E Ratio | $85.33 | ★ N/A |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $34.63 | $20.40 |
| 52 Week High | $60.44 | $42.74 |
Technical Indicators
Market Signals| Indicator | RPRX | DOW |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 48.26 |
| Support Level | $54.95 | $28.72 |
| Resistance Level | $58.84 | $35.51 |
| Average True Range (ATR) | 1.30 | 1.05 |
| MACD | -0.21 | 0.17 |
| Stochastic Oscillator | 37.99 | 38.78 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in consumer and industrial end markets.